Welcome to the News Room

Yesterday, June 16th 2015, Prof Meir Pugatch presented the findings of two of Pugatch Consilium’s latest studies at an opening plenary session of the International BIO Convention in Philadelphia, Pennsylvania. During the session, Prof Pugatch discussed empirical measures of national biopharmaceutical environments, including the Biopharmaceutical Competitiveness & Investment (BCI) Survey and Building the Bioeconomy 2015, and how these tools can be used to shed light on emerging opportunities and challenges in global biotech markets.

The results of the two studies are also being presented in additional panels ...

Economies’ policy trajectories have a significant impact on biopharmaceutical investment decisions, perhaps more than costs and market size, according to local executives. Our new study, Measuring the Global Biomedical Pulse: The Biopharmaceutical Investment & Competitiveness (BCI) Survey, finds that economies with policy environments that support investment and innovation rank as the most attractive for biopharmaceutical investment in the eyes of top level executives operating on the ground. The study, commissioned by PhRMA, also finds that notwithstanding low costs and considerable ...

Today Pugatch Consilium launches Building the Bioeconomy 2015 the second edition study of the policies and best practices that pave the way for a creating an environment and ecosystem that enables biotech innovation. The 2015 edition focuses on 13 countries: Brazil, China, India, Korea, Malaysia, Mexico, Russia, Singapore, South Africa, Switzerland, Turkey, the UK and the United States. Using a comparative perspective and looking in detail at the country specific-level, the report identifies several important findings as well as lessons learned.

The report identifies ...

Pugatch Consilium’s Prof. Meir Pugatch and Rachel Chu publish an article in fDi Magazine (http://www.fdiintelligence.com/) on how building an innovation culture can help countries prepare for the outbreak of diseases such as Ebola. The article is part of Pugatch Consilium’s ongoing analysis and intelligence database on biopharmaceutical investment and innovation policy.

How to stay one step ahead of an outbreak  – Read more on our Research & Analysis Reports Page